Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine-Reference-Cited by-同舟云学术

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine

Published:2018-06 Issue: Volume:9 Page:330-346
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Carlsson Leif,Clarke Jonathan C.,Yen Christopher,Gregoire Francine,Albery Tamsin,Billger Martin,Egnell Ann-Charlotte,Gan Li-Ming,Jennbacken Karin,Johansson Edvin,Linhardt Gunilla,Martinsson Sofia,Sadiq Muhammad Waqas,Witman Nevin,Wang Qing-Dong,Chen Chien-Hsi,Wang Yu-Ping,Lin Susan,Ticho Barry,Hsieh Patrick C.H.,Chien Kenneth R.,Fritsche-Danielson Regina

Funder

National Laboratory Animal Center, Tainan, Taiwan

AstraZeneca

Takeda

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference59 articles.

1. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus;Selvin;Ann. Intern. Med.,2004

2. Epidemiology of peripheral artery disease;Criqui;Circ. Res.,2015

3. Heart disease and stroke statistics—2015 update: a report from the American Heart Association;Mozaffarian;Circulation,2015

4. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis;Henry;Circulation,2003

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Further therapeutic applications of mRNA and saRNA;mRNA Therapeutics;2025

2. Protein isoform-centric therapeutics: expanding targets and increasing specificity;Nature Reviews Drug Discovery;2024-09-04

3. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy;Journal of Controlled Release;2024-08

4. Therapeutic nucleic acids in regenerative medicine and tissue repair;Nano Research;2024-07-13

5. RNA in cardiovascular disease: A new frontier of personalized medicine;Progress in Cardiovascular Diseases;2024-07